Marriott San Francisco Marquis, Golden Gate Ballroom A/B
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.

---

Program Description

Please join pulmonologists Ayodeji Adegunsoye, MD and Michael Zlupko, MD as they share their different perspectives of diagnosing and managing patients with idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases in both academic and private practice settings. They will share insights into delays in diagnosis, the importance of high resolution computed tomography (HRCT) imaging, and challenges and unmet educational needs that physicians and patients may face. During this program, attendees will also hear directly from a patient living with IPF and learn more about her journey.

A symposium presentation at the ATS 2025 International Conference.

This presentation is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and is open to all ATS 2025 International Conference attendees.

This is a non-CME event and does not qualify for CME or CE credit. Onsite registration/admission will occur for conference registrants only at the symposium entrance, on a first-come, first-serve basis.

Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing medical education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted. (03/25) EM-US-103751

Speakers

Presenter: Ayodeji Adegunsoye, MD
University of Chicago Medicine
Pulmonary and Critical Care
Assistant Professor of Medicine
Chicago, Illinois

Presenter: Michael Zlupko, MD
Altoona Lung Specialists
Pulmonary & Critical Care Physician
Altoona, Pennsylvania